Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Bacterial 16S ribosomal RNA A-site is a highly conserved region within the 30S ribosomal subunit that serves as the primary decoding center during protein translation (Vicens & Westhof, 2001, Chem & Bio). Its fundamental role is to ensure the accuracy of the genetic code by facilitating the selection of the correct aminoacyl-tRNA based on the mRNA codon (PubMed, PMC351914). This site is the principal pharmacological target for aminoglycoside antibiotics, which bind to the internal loop of the A-site and stabilize a 'flipped-out' conformation of adenine residues A1492 and A1493 (StatPearls, 2023). This structural alteration reduces the energy barrier for non-cognate tRNA binding, causing the ribosome to misread mRNA and produce aberrant proteins that disrupt bacterial cell membrane integrity (NIH, NBK541077). While highly effective against Gram-negative and some Gram-positive bacteria, drugs targeting this site can cause toxicity in humans due to structural similarities between the bacterial A-site and the human mitochondrial 12S rRNA A-site (PubMed, 12596201). Therapeutic challenges include the emergence of resistance mediated by 16S rRNA methyltransferases, which chemically modify the A-site to prevent drug binding (PubMed, 17307716).
Aminoglycosides bind to the 16S rRNA A-site, inducing a conformational change in residues A1492 and A1493 that mimics correct codon-anticodon pairing, leading to mistranslation and protein synthesis inhibition (StatPearls, 2023; Vicens & Westhof, 2001).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial 16S ribosomal RNA A-site (16S rRNA A-site) (16S rRNA A-site).